News
Calyxt Announces Stockholder Approval of Merger With Cibus
May 19, 2023
—Calyxt Announces 1-for-5 Reverse Stock Split of Common Stock— ROSEVILLE, MN, May 19, 2023 (PR NEWSWIRE) – Calyxt, Inc. (Nasdaq:...
Read More
Calyxt Reports First Quarter 2023 Financial Results and Provides Corporate Update
May 1, 2023
—Proposed merger with Cibus Global Expected to Close in Q2 2023— —1-for-10 reverse stock split executed— —Current customer projects under...
Read More
Calyxt Completes One-for-Ten Reverse Stock Split
April 24, 2023
ROSEVILLE, MN, April 24, 2023 (PR NEWSWIRE) – Calyxt, Inc. (Nasdaq: CLXT) (“Calyxt” or the “Company”) today announced that it...
Read More
Calyxt, Inc. Announces Effectiveness of Registration Statement on Form S-4 in Connection with Merger with Cibus Global LLC
April 18, 2023
ROSEVILLE, Minn. and SAN DIEGO– April 18, 2023 /PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biology company, and...
Read More
Calyxt Announces Effective Date of Reverse Stock Split
April 7, 2023
ROSEVILLE, MN, April 7, 2023 (PR NEWSWIRE) – Calyxt, Inc. (Nasdaq: CLXT) (“Calyxt” or the “Company”) today announced that it...
Read More